Mariam De La Poza Abad

Dr. Mariam De La Poza Abad

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2018 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
MMMiguel A. Martinez-Gonzalez
Miguel A. Martinez-Gonzalez
PBPilar Buil-Cosiales
Pilar Buil-Cosiales
DCDolores Corella
Dolores Corella
MBMonica Bullo
Monica Bullo
MFMontserrat Fitó
Montserrat Fitó
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó
The PREDIMED (in Spanish: PREvención con DIeta MEDiterránea) primary prevention trial 1–3 reported in 2013 that long-term adherence to an energy-unrestricted Mediterranean diet (MedDiet), supplemented with either extra-virgin olive oil (EVOO) or nuts, reduced cardiovascular disease (CVD). PREDIMED showed a 30% relative reduction in the composite cardiovascular primary endpoint (stroke, myocardial infarction or cardiovascular death). 2,, 3 However, the PREDIMED trial tested only the composition of the diet, but did not test other lifestyle interventions (i.e. energy reduction, increased physical activity (PA) and behavioural modification) frequently applied in the context of the current unprecedented obesity pandemic. 4,, 5 With the exception of the null results of the Look-AHEAD trial, 6 and the successful results of the EXERDIET-HTA study that found improvements in blood pressure, cardio-respiratory fitness and body composition (though they encouraged adherence to an hypocaloric DASH diet, instead of a Mediterranean diet), 7 lifestyle interventions including such components have never been tested in long-term randomized trials using hard cardiovascular events as endpoints.

5 August 2019 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
NBNerea Becerra-Tomás
Nerea Becerra-Tomás
Lucía Camacho-BarciaLucía Camacho-Barcia
Lucía Camacho-Barcia
GMGuillermo Mena-Sánchez
Guillermo Mena-Sánchez
ADAndrés Díaz-López
Andrés Díaz-López
MMMiguel Ángel Martínez-González
Miguel Ángel Martínez-González
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó

26 March 2019 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
MAMariam De La Poza Abad
Mariam De La Poza Abad
GDGemma Mas Dalmau
Gemma Mas Dalmau
IGIgnasi Gich
Ignasi Gich
LGLaura Martínez García
Laura Martínez García
CLCarl Llor
Carl Llor
PAPablo Alonso
Pablo Alonso
One of several strategies developed to reduce inappropriate antibiotic use in situations where the indication is not clear is delayed antibiotic prescription (DAP), defined as an antibiotic prescription issued for the patient to take only in case of feeling worse or not feeling better several days after the visit. We conducted a survey to identify DAP use in Spanish primary care settings. We surveyed 23 healthcare centers located in 4 autonomous regions where a randomized controlled trial (RCT) on DAP was underway. The primary variable was use of DAP. Categorical and quantitative variables were analyzed by means of the chi-squared test and non-parametric tests, respectively. The survey was sent to 375 healthcare professionals, 215 of whom responded (57.3% response rate), with 46% of these respondents declaring that they had used DAP in routine practice before the RCT started (66.6% afterwards), mostly (91.5%) for respiratory tract infections (RTIs), followed by urinary infections (45.1%). Regarding DAP use for RTIs, the most frequent conditions were pharyngotonsillitis (88.7%), acute bronchitis (62.7%), mild chronic obstructive pulmonary disease exacerbations (59.9%), sinusitis (51.4%), and acute otitis media (45.1%). Most respondents considered that DAP reduced emergency visits (85.4%), scheduled visits (79%) and inappropriate antibiotic use (73.7%) and most also perceived patients to be generally satisfied with the DAP approach (75.6%). Having participated or not in the DAP RCT (74.1% versus 46.2%; p < 0.001), having previously used or not used DAP (86.8% versus 44.2%; p < 0.001), and being a physician versus being a nurse (81.8% versus 18.2%; p < 0.001) were factors that reflected significantly higher rates of DAP use. The majority of primary healthcare professionals in Spain do not use DAP. Those who use DAP believe that it reduces primary care visits and inappropriate antibiotic use, while maintaining patient satisfaction. Given the limited use of DAP in our setting, and given that its use is mainly limited to RTIs, DAP has considerable potential in terms of its implementation in routine practice.

13 September 2012 in AIDS Care
Verified
Journal Article
Closed access
CAC. Agustí
C. Agustí
LFL. Fernàndez-López
L. Fernàndez-López
JMJ. Mascort
J. Mascort
RCR. Carrillo
R. Carrillo
CAC. Aguado
C. Aguado
JCJ. Casabona
J. Casabona
This study reveals a high level of acceptance and willingness on the part of GPs to offer rapid HIV testing in their practices. Nevertheless, the implementation of rapid HIV testing in primary care will not be possible without moving from comprehensive pre-test counselling towards brief pre-test information and improving training in the use of rapid tests.

28 August 2013 in HIV Medicine
Verified
Journal Article
Open access
PDF file
CAC Agustí
C Agustí
LFL Fernàndez‐López
L Fernàndez‐López
JMJ Mascort
J Mascort
RCR Carrillo
R Carrillo
CAC Aguado
C Aguado
JCJ Casabona
J Casabona
Objectives: The objectives of this study were to investigate the acceptability of rapid HIV testing among general practitioners in Spain and to identify perceived barriers and needs in order to implement rapid testing in primary care settings.Methods: An anonymous questionnaire was distributed online to all members of the two largest Spanish scientific medical societies for family and community medicine. The study took place between 15th June and 31st October 2010.Results: Completed questionnaires were returned by 1308 participants. The majority (90.8%) of respondents were General Practitioners (GP). Among all respondents, 70.4% were aware of the existence of rapid tests for the diagnosis of HIV but they did not know how to use them. Nearly 80% of participants would be willing to offer rapid HIV testing in their practices and 74.7% would be confident of the results obtained by these tests. The barriers most commonly identified by respondents were a lack of time and a need for training, both in the use of rapid tests (44.3% and 56.4%, respectively) and required pre‐ and post‐test counselling (59.2% and 34.5%, respectively).Conclusions: This study reveals a high level of acceptance and willingness on the part of GPs to offer rapid HIV testing in their practices. Nevertheless, the implementation of rapid HIV testing in primary care will not be possible without moving from comprehensive pre‐test counselling towards brief pre‐test information and improving training in the use of rapid tests.

19 May 2013 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
MAMariam De La Poza Abad
Mariam De La Poza Abad
GDGemma Mas Dalmau
Gemma Mas Dalmau
MBMikel Moreno Bakedano
Mikel Moreno Bakedano
AGAna Isabel González-González
Ana Isabel González-González
YCYolanda Canellas Criado
Yolanda Canellas Criado
FGfor the Delayed Antibiotic Prescription (DAP) Working Group
for the Delayed Antibiotic Prescription (DAP) Working Group
Background: Respiratory tract infections are an important burden in primary care and it’s known that they are usually self-limited and that antibiotics only alter its course slightly. This together with the alarming increase of bacterial resistance due to increased use of antimicrobials calls for a need to consider strategies to reduce their use. One of these strategies is the delayed prescription of antibiotics. Methods: Multicentric, parallel, randomised controlled trial comparing four antibiotic prescribing strategies in acute non-complicated respiratory tract infections. We will include acute pharyngitis, rhinosinusitis, acute bronchitis and acute exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (mild to moderate). The therapeutic strategies compared are: immediate antibiotic treatment, no antibiotic treatment, and two delayed antibiotic prescribing (DAP) strategies with structured advice to use a course of antibiotics in case of worsening of symptoms or not improving (prescription given to patient or prescription left at the reception of the primary care centre 3 days after the first medical visit). Discussion: Delayed antibiotic prescription has been widely used in Anglo-Saxon countries, however, in Southern Europe there has been little research about this topic. The DAP trial wil evaluate two different delayed strategies in Spain for the main respiratory infections in primary care. Trial registration: This trial is registered with ClinicalTrials.gov, number http://NCT01363531.